首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1547470

全球女性健康治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Women Health Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球女性健康治療市場需求預計將從 2023 年的 882.8 億美元達到近 1,506.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.12%。

用於診斷妊娠相關併發症、感染、子宮頸癌、卵巢癌和子宮癌等問題的治療、療法或藥物被稱為女性健康療法。如今，女性不孕症病例不斷增加，因此為延遲生育者提供生育服務越來越受到重視。而且，女性性功能障礙治療的未滿足需求導致了對女性健康治療的需求。

市場動態

對女性健康及其治療的認知不斷提高是女性健康治療市場成長的關鍵市場驅動力。為了滿足與感染、癌症、懷孕等問題的治療相關的未滿足的藥物需求而進行的高投資也是女性健康治療市場成長的主要驅動力之一。與女性健康相關的慢性疾病預防的日益普及也被認為將引導女性健康治療的市場成長。為女性提供更好健康的研發舉措的增加將進一步推動市場成長。此外，不良的營養攝取和生活方式的改變預計也會增加對治療藥物的需求，並刺激女性健康治療藥物的市場成長。然而，與治療相關的高治療成本以及與治療方法的使用相關的副作用可能會限制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球女性健康治療市場的每個細分市場進行了包容性評估。女性健康治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

女性健康治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按治療類型

荷爾蒙治療（雌激素治療、黃體素治療、合併治療、甲狀腺替代治療、副甲狀腺素治療等）
非荷爾蒙治療（標靶治療藥物、抗生素、雙磷酸鹽等）

按疾病適應症

癌症（乳癌、子宮頸癌、卵巢癌）
甲狀腺功能低下症
停經後綜合症
骨質疏鬆症
避孕
子宮肌瘤
泌尿道感染
其他

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲女性健康治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。女性健康治療市場的主要參與者包括禮來公司、諾華公司、輝瑞公司、默克公司、諾和諾德公司、安進公司、阿斯特捷利康、霍夫曼-拉羅氏有限公司、賽諾菲( Sanofi)、艾爾建(Allergan Plc)、葛蘭素史克(GlaxoSmithKline Plc)、盧平製藥(Lupin Pharmaceuticals Inc.) 本節包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：女性健康療癒公司的競爭格局

女性健康治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Eli Lilly And Company

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Novo Nordisk A/S

公司概況
公司收入
產品
最新動態

Amgen Inc.

公司概況
公司收入
產品
最新動態

AstraZeneca

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Allergan Plc

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

Lupin Pharmaceuticals Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215203

The global demand for Women Health Therapeutics Market is presumed to reach the market size of nearly USD 150.68 Billion by 2032 from USD 88.28 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.

A treatment, therapy, or drug that is used for the diagnosis of issues like pregnancy-related complications, infection, cervical cancer, ovarian cancer, and uterine cancer, etc is known as women's health therapeutics. Nowadays, infertility cases in women are rising, so the focus on providing fertility services to those with delayed childbirth is increasing. And, the unmet needs of the treatment of female sexual dysfunction are leading to the demand for women's health therapeutics.

MARKET DYNAMICS

Rising awareness about women's health and its treatment is the key market driver for the growth of the women's health therapeutics market. High investments made to meet the unmet demands of drugs related to the treatment of issues like infections, cancer, pregnancy, etc is also one of the major driving force responsible for the market growth of women health therapeutics. The growing prevalence of prevention of chronic diseases related to women's health is also assumed to steer the market growth of women's health therapeutics. An increase in research and development initiatives for providing better health to women will further propel the market growth. Furthermore, bad nutritional intake and change in lifestyle are also expected to increase the demand for therapeutics and exhilarate the market growth of women's health therapeutics. However, the high treatment cost associated with the treatment and side effects associated with the usage of the therapeutics may restraint the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Women Health Therapeutics. The growth and trends of Women Health Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Women Health Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others)

By Disease Indication

Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer)
Hypothyroidism
Post-menopausal Syndrome
Osteoporosis
Contraception
Uterine Fibroid
Urinary Tract Infection
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Women Health Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Women Health Therapeutics market include Eli Lilly And Company, Novartis AG, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, GlaxoSmithKline Plc, Lupin Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WOMEN HEALTH THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

5.1. Overview By Treatment Type
5.2. Historical and Forecast Data Analysis By Treatment Type
5.3. Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Historic and Forecast Sales By Regions
5.4. Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Historic and Forecast Sales By Regions

6. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY DISEASE INDICATION

6.1. Overview By Disease Indication
6.2. Historical and Forecast Data Analysis By Disease Indication
6.3. Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Historic and Forecast Sales By Regions
6.4. Hypothyroidism Historic and Forecast Sales By Regions
6.5. Post-menopausal Syndrome Historic and Forecast Sales By Regions
6.6. Osteoporosis Historic and Forecast Sales By Regions
6.7. Contraception Historic and Forecast Sales By Regions
6.8. Uterine Fibroid Historic and Forecast Sales By Regions
6.9. Urinary Tract Infection Historic and Forecast Sales By Regions
6.10. Others Historic and Forecast Sales By Regions

7. GLOBAL WOMEN HEALTH THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE WOMEN HEALTH THERAPEUTICS COMPANIES

8.1. Women Health Therapeutics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF WOMEN HEALTH THERAPEUTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Eli Lilly And Company
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Pfizer Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Merck & Co. Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Novo Nordisk A/S
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Amgen Inc.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. AstraZeneca
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. F. Hoffmann-La Roche Ltd.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sanofi
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Allergan Plc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. GlaxoSmithKline Plc
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Lupin Pharmaceuticals Inc
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Treatment Type (USD MN)
Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Market Sales By Geography (USD MN)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Market Sales By Geography (USD MN)
Analysis By Disease Indication (USD MN)
Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Market Sales By Geography (USD MN)
Hypothyroidism Market Sales By Geography (USD MN)
Post-menopausal Syndrome Market Sales By Geography (USD MN)
Osteoporosis Market Sales By Geography (USD MN)
Contraception Market Sales By Geography (USD MN)
Uterine Fibroid Market Sales By Geography (USD MN)
Urinary Tract Infection Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Women Health Therapeutics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Women Health Therapeutics Report
Market Research Process
Market Research Methodology
Global Women Health Therapeutics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Treatment Type
Market Attractiveness Analysis By Disease Indication
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Treatment Type (USD MN)
Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others) Market Sales By Geography (USD MN)
Non-hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, Others) Market Sales By Geography (USD MN)
Global Market Analysis By Disease Indication (USD MN)
Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer) Market Sales By Geography (USD MN)
Hypothyroidism Market Sales By Geography (USD MN)
Post-menopausal Syndrome Market Sales By Geography (USD MN)
Osteoporosis Market Sales By Geography (USD MN)
Contraception Market Sales By Geography (USD MN)
Uterine Fibroid Market Sales By Geography (USD MN)
Urinary Tract Infection Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis